In reply: While Zhou and colleagues disagree with our viewpoint that Australian “women planning a pregnancy and pregnant and lactating women should be advised to take an iodine supplement”,1 we note that they suggest any such recommendation should await the results of their planned randomised controlled trial (RCT) examining the effects of maternal iodine supplementation on maternal health and neurodevelopmental outcome of the offspring. They neglect to mention that the National Health and Medical Research Council (NHMRC) issued a public statement in January this year, with supporting evidence attached, stating that: “The NHMRC recommends that all women who are pregnant, breastfeeding or considering pregnancy take an iodine supplement of 150 μg each day”.2 Similar recommendations, based upon available scientific evidence, have been issued by the World Health Organization, International Council for Control of Iodine Deficiency Disorders, American Thyroid Association and American Endocrine Society.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Gisselle Gallego and Stephen Goodall coauthored reports for FSANZ and the Department of Health and Ageing on the cost-effectiveness of iodine fortification of bread in Australia and NZ. Stephen Goodall is an FSANZ fellow. Creswell Eastman is the vice-chairman of the International Council for Control of Iodine Deficiency Disorders, which is supported by the Australian Government Overseas Aid Program and the Canadian International Development Agency. Creswell Eastman is patron of the Australian Thyroid Foundation, which has received support from Cerebos (manufacturer of Saxa salt) and Blackmores.